5323952026-06-135323952026-06-132026-06-135323952026-06-132026-06-13UnitOrDivisionOrSubsidiaryDomain15323952026-06-13UnitOrDivisionOrSubsidiaryDomain1iso4217:INRxbrli:pure532395AXISCADES Technologies LimitedAXISCADESNOTLISTEDINE555B01013NewSale or disposal of unit(s)/division(s)/subsidiarytrue2026-06-1215:00:002026-06-13‘Engineering Services’ in the Aerospace industryDivision‘Engineering Services’ in the Aerospace industry (“Transferring Business”) by the Company, its branches in Germany and France, and its subsidiaries namely, Cades Studec Technologies (India) Private Limited (“CSTI”), AXISCADES GmbH (“ATL Germany”), AXISCADES UK Limited (“ATL UK”), AXISCADES Technology Canada Inc. (“ATL Canada”) and AXISCADES Inc (“ATL US”)32259000000.3132259000000.3132259000000.317430000000.1132026-06-122026-11-30Cash and SharesThe aggregate consideration payable at the time of closing of Business Transfers is USD 152.35 million, subject to any adjustments in terms of the Transaction Documents. This has been determined basis the valuation report obtained from M/s SSPA & Co., Chartered Accountants. The said consideration shall be settled in accordance with the Transaction Documents. The Company shall be issued additional by way of shares in New India Co. for a part of the consideration payable to it for the sale of its Transferring Business.and cash. The aggregate consideration for the Proposed Transaction is USD 206.30 million, receivable as follows: (i) Tranche 1 - an aggregate cash consideration of USD 77.70 million, receivable at the time of India Fund Infusion and Overseas Fund Infusion, subject to any adjustments as per terms of the Transaction Documents. The Company shall be additionally issued shares in New India Co. for the balance part of the sale of its Transferring Business and said shares shall be transferred in Tranche 2. Please refer to Schedule I for more details on the manner of settlement of the consideration. (ii) Tranche 2 - a payment of USD 76.02 million, post 24 months of the closing of infusion of the funds, along with an additional performance-linked contingent payment up to USD 52.58 million, subject to any adjustments as per the terms of the Transaction Documents.(i) The Transferring Business of the Company, and Cades Studec Technologies (India) Private Limited is proposed to be transferred to New India Co (a new subsidiary proposed to be incorporated by the Company in India); (ii) The Transferring Business of German and French branches of ATL, ATL Germany, ATL UK, ATL Canada and ATL USA to the subsidiaries to be acquired/ incorporated in the respective overseas jurisdictions by the Overseas Hold Co (a new subsidiary proposed to be acquired by the Company in Switzerland). As specified above, the buyers are subsidiaries/step-down subsidiaries of the Company.falsetrue2026-06-122026-06-11true2026-06-12truetrueThe transaction does not form part of any Scheme of Arrangement. The Company shall obtain necessary approvals under Section 180 of the Companies Act, 2013 and Regulation 37A of the LODR Regulations. Further, necessary disclosures required as per Regulation 37A of the Listing Regulations shall be made in the Notice of Postal Ballot for obtaining approval of the shareholderstrue